PWS Outcomes Assessment Study

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

June 8, 2021

Study Completion Date

June 8, 2021

Conditions
Prader-Willi Syndrome
Interventions
OTHER

Interview

Qualitative Interview

Trial Locations (1)

02360

Casimir Trials, Plymouth

All Listed Sponsors
collaborator

Casimir Trials

UNKNOWN

lead

Soleno Therapeutics, Inc.

INDUSTRY

NCT04102839 - PWS Outcomes Assessment Study | Biotech Hunter | Biotech Hunter